FDA Inspection 1320892 — Curium Netherlands B.V.

Curium Netherlands B.V. — FEI 3002806617

The FDA completed an inspection of Curium Netherlands B.V. on May 17, 2024 in Petten. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 17, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Petten (Netherlands)

Additional Details

Mutual Recognition Agreement (MRA)